WP
IMNM icon

Woodline Partners’s Immunome IMNM Stock Holding History

Woodline Partners’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.5M Hold
1,575,398
– – 0.13% 211
2025
Q4 		$33.8M Buy
1,575,398
+300,669
+24% +$5.28M 0.13% 202
2025
Q3 		$14.9M Sell
1,274,729
-383,934
-23% -$3.82M 0.07% 342
2025
Q2 		$15.4M Buy
1,658,663
+934
+0.1% +$7.66K 0.08% 342
2025
Q1 		$11.2M Buy
1,657,729
+676,804
+69% +$6.49M 0.07% 341
2024
Q4 		$10.4M Buy
980,925
+56,533
+6% +$683K 0.07% 333
2024
Q3 		$13.5M Buy
924,392
+1,500
+0.2% +$21.3K 0.11% 244
2024
Q2 		$11.2M Sell
922,892
-395,164
-30% -$6.18M 0.11% 237
2024
Q1 		$32.5M Buy
1,318,056
+395,164
+43% +$8.02M 0.3% 100
2023
Q4 		$9.87M Buy
+922,892
New +$7.67M 0.11% 230

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Woodline Partners's IMNM Position: Q1 2026 in Review

Woodline Partners held its Immunome (IMNM) position steady in Q1 2026 at 1,575,398 shares worth $34.5M. The position accounts for 0.13% of the portfolio, ranked #211.

Woodline Partners first reported a position in IMNM in Q4 2023 and has held it in 10 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Woodline Partners held 1,575,398 shares of Immunome worth $34.5M as of Q1 2026.
  • Woodline Partners left its Immunome share count unchanged in Q1 2026.
  • Immunome made up 0.13% of Woodline Partners's portfolio in Q1 2026, its #211 holding.
  • Woodline Partners first reported a position in Immunome in Q4 2023 and has held it in 10 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.